# Taizhou Xianju Pharmaceutical Co. Ltd. – FDA Inspection, Mar 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/taizhou-xianju-pharmaceutical-co-ltd/c928eb35-fe18-41ef-b120-6c5e93656bb3
Source feed: FDA_Inspections

> FDA inspection 1009605 of Taizhou Xianju Pharmaceutical Co. Ltd., March 31, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009605
- Company Name: Taizhou Xianju Pharmaceutical Co. Ltd.
- Inspection Date: 2017-03-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1256835 - 2024-11-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tajah-l-blackburn/27b25d9d-3186-4b3a-a511-2f693d3c889a)

Company: https://www.keypedia.com/companies/taizhou-xianju-pharmaceutical-co-ltd/4b333061-9eb4-463f-9489-f78b16b0014d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c